NASDAQ: VERV Lawsuit ALERT: Investors Who Lost Money With Shares of Verve Therapeutics, Inc. (NASDAQ: VERV) Should Contact the Shareholders Foundation

Read Time:2 Minute, 0 Second

A lawsuit was filed for certain investors in Verve Therapeutics, Inc. (NASDAQ:VERV) shares. Investors in NASDAQ: VERV shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Verve Therapeutics, Inc. (NASDAQ:VERV) shares.

mail@shareholdersfoundation.com
mail@shareholdersfoundation.com
Shareholders Foundation – mail@shareholdersfoundation.com or +1(858) 779 – 1554

Investors that purchased shares of Verve Therapeutics, Inc. (NASDAQ: VERV) have certain options and for certain investors are short and strict deadlines running. Deadline: October 28, 2024. NASDAQ: VERV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

On August 27, 2024, a lawsuit was filed by an investor in NASDAQ: VERV shares against Verve Therapeutics, Inc. over alleged securities laws violations. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose, among other things, that defendants did not fully disclose the circumstances under which the Heart-1 Phase 1b clinical trial (the “Heart-1 Trial”) of VERVE-101 would be halted (VERVE-101 is an investigational gene editing medicine designed to be a single course treatment that permanently turns off the PCSK9 gene in the liver to reduce disease-driving low-density lipoprotein cholesterol (LDL-C)), that the defendants overstated the potential benefits of its proprietary lipid nanoparticle (LNP) delivery system, and that as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times

Those who purchased Verve Therapeutics, Inc. (NASDAQ: VERV) shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Contact Information

Michael Daniels
Manager
mail@shareholdersfoundation.com
858-779-1554

SOURCE: Shareholders Foundation, Inc.

Related Media

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Mentavi Health Partners with NEI to Elevate Clinician Training and Expertise
Next post TeaZa® Energy Secures Gold in 2024 CStore Decisions Hot New Products Contest